Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rajendran Selvakumar, Dhanabalan Anantha Krishnan, Chandrasekaran Ramakrishnan, Devadasan Velmurugan & Krishnasamy Gunasekaran. (2020) Identification of novel NAD(P)H dehydrogenase [quinone] 1 antagonist using computational approaches. Journal of Biomolecular Structure and Dynamics 38:3, pages 682-696.
Read now
Read now
Anna Maciag & Lucy M. Anderson. (2004) Reactive Oxygen Species And Lung Tumorigenesis By Mutant K-: A Working Hypothesis. Experimental Lung Research 31:1, pages 83-104.
Read now
Read now
Simone Benhamou , Christine Bouchardy, Anu Voho, Katja Mitrunen, Pierre Dayer & Ari Hirvonen. (2001) Role of NAD(P)H:quinone oxidoreductase polymorphism at codon 187 in susceptibility to lung, laryngeal and oral/pharyngeal cancers. Biomarkers 6:6, pages 440-447.
Read now
Read now
Articles from other publishers (25)
Li Yuhan, Maryam Khaleghi Ghadiri & Ali Gorji. (2024) Impact of NQO1 dysregulation in CNS disorders. Journal of Translational Medicine 22:1.
Crossref
Crossref
Shilin Luo, Kecheng Lei, Daxiong Xiang & Keqiang Ye. (2018) NQO1 Is Regulated by PTEN in Glioblastoma, Mediating Cell Proliferation and Oxidative Stress. Oxidative Medicine and Cellular Longevity 2018, pages 1-16.
Crossref
Crossref
Jiawen Huang, Huiran Lin, Xiaosong Wu, Weijun Jin & Zhidong Zhang. (2017)
NQO1
C609T polymorphism and lung cancer susceptibility: Evidence from a comprehensive meta-analysis
. Oncotarget 8:60, pages 102301-102309.
Crossref
Crossref
Eun-Taex Oh & Heon Joo Park. (2015) Implications of NQO1 in cancer therapy. BMB Reports 48:11, pages 609-617.
Crossref
Crossref
Yuqing Lou, Rong Li, Liwen Xiong, Aiqin Gu, Chunlei Shi, Tianqing Chu, Xueyan Zhang, Ping Gu, Hua Zhong, Shaojun Wen & Baohui Han. (2013) NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis. Tumor Biology 34:6, pages 3967-3979.
Crossref
Crossref
A. L. Marshall & D. C. Christiani. (2013) Genetic susceptibility to lung cancer--light at the end of the tunnel?. Carcinogenesis 34:3, pages 487-502.
Crossref
Crossref
Si Yeol Song, Seong-Yun Jeong, Heon Joo Park, Seung-Il Park, Dong Kwan Kim, Yong Hee Kim, Seong Soo Shin, Sang-wook Lee, Seung Do Ahn, Jong Hoon Kim, Jung Shin Lee & Eun Kyung Choi. (2010) Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer. Lung Cancer 68:2, pages 278-282.
Crossref
Crossref
Peter Gresner, Jolanta Gromadzinska & Wojciech Wasowicz. (2007) Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57:1, pages 1-25.
Crossref
Crossref
Kwang Seok Ahn, Gautam Sethi, Abhinav K. Jain, Anil K. Jaiswal & Bharat B. Aggarwal. (2006) Genetic Deletion of NAD(P)H:Quinone Oxidoreductase 1 Abrogates Activation of Nuclear Factor-κB, IκBα Kinase, c-Jun N-terminal Kinase, Akt, p38, and p44/42 Mitogen-activated Protein Kinases and Potentiates Apoptosis. Journal of Biological Chemistry 281:29, pages 19798-19808.
Crossref
Crossref
YaHsin Cheng, Louis W. Chang & Tsui-Chun Tsou. (2005) Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells. Archives of Toxicology 80:6, pages 310-318.
Crossref
Crossref
Chun Chao, Zuo-Feng Zhang, Julien Berthiller, Paolo Boffetta & Mia Hashibe. (2006)
NAD(P)H:Quinone Oxidoreductase 1 (
NQO1
) Pro187Ser Polymorphism and the Risk of Lung, Bladder, and Colorectal Cancers: a Meta-analysis
. Cancer Epidemiology, Biomarkers & Prevention 15:5, pages 979-987.
Crossref
Crossref
Karla A. Lawson, Karen Woodson, Jarmo Virtamo & Demetrius Albanes. (2005)
Association of the NAD(P)H:Quinone Oxidoreductase (
NQO1
) 609C→T Polymorphism with Lung Cancer Risk among Male Smokers
. Cancer Epidemiology, Biomarkers & Prevention 14:9, pages 2275-2276.
Crossref
Crossref
Salvador J. Saldivar, Yunfei Wang, Hua Zhao, Lina Shao, Jie Lin, Margaret R. Spitz & Xifeng Wu. (2005) An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 582:1-2, pages 71-78.
Crossref
Crossref
Xifeng Wu, Hua Zhao, Rebecca Suk & David C Christiani. (2004) Genetic susceptibility to tobacco-related cancer. Oncogene 23:38, pages 6500-6523.
Crossref
Crossref
Anna-Karin Alexandrie, Fredrik Nyberg, Margareta Warholm & Agneta Rannug. (2004)
Influence of
CYP1A1
,
GSTM1
,
GSTT1
, and
NQO1
Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population
. Cancer Epidemiology, Biomarkers & Prevention 13:6, pages 908-914.
Crossref
Crossref
David Ross & David Siegel. 2004. Quinones and Quinone Enzymes, Part B. Quinones and Quinone Enzymes, Part B
115
144
.
Louise Lyrenäs, Emma Wincent, Lena Forsberg, Ulf de Faire & Ralf Morgenstern. 2003. Redox-Genome Interactions in Health and Disease. Redox-Genome Interactions in Health and Disease.
Ji-Yeob Choi, Kyoung-Mu Lee, Soo-Hun Cho, Soo-Woong Kim, Han-Yong Choi, Sang-Yoon Lee, Hyoung-June Im, Ki Jung Yoon, Hwang Choi, Inmi Choi, Ari Hirvonen, Richard B Hayes & Daehee Kang. (2003) CYP2E1 and NQO1 genotypes, smoking and bladder cancer. Pharmacogenetics 13:6, pages 349-355.
Crossref
Crossref
Seun-Ja Park, Hua Zhao, Margaret R Spitz, H Barton Grossman & Xifeng Wu. (2003) An association between NQO1 genetic polymorphism and risk of bladder cancer. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 536:1-2, pages 131-137.
Crossref
Crossref
Geraldine A. Finlay, Brenda Joseph, Cynthia R. Rodrigues, John Griffith & Alexander C. White. (2002) Advanced Presentation of Lung Cancer in Asian Immigrants. Chest 122:6, pages 1938-1943.
Crossref
Crossref
Chikako Kiyohara, Akiko Otsu, Taro Shirakawa, Sanae Fukuda & Julian M Hopkin. (2002) Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 37:3, pages 241-256.
Crossref
Crossref
Ahlke Strassburg, Christian P. Strassburg, Michael P. Manns & Robert H. Tukey. (2002)
Differential Gene Expression of
NAD(P)H:Quinone Oxidoreductase
and
NRH:Quinone Oxidoreductase
in Human Hepatocellular and Biliary Tissue
. Molecular Pharmacology 61:2, pages 320-325.
Crossref
Crossref
Sarah J Lewis, Nicola M Cherry, Robert McL Niven, Phillip V Barber & Andrew C Povey. (2001) Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population. Lung Cancer 34:2, pages 177-183.
Crossref
Crossref
L. Yin, Y. Pu, T.-Y. Liu, Y.-H. Tung, K.-W. Chen & P. Lin. (2001) Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer 33:2-3, pages 133-141.
Crossref
Crossref
Sukhdev S. BrarThomas P. KennedyA. Richard WhortonAnne B. Sturrock, Thomas P. Huecksteadt, Andrew J. Ghio & John R. Hoidal. (2001) Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-κB in malignant melanoma cells. American Journal of Physiology-Cell Physiology 280:3, pages C659-C676.
Crossref
Crossref